LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

LifeMD (Nasdaq: LFMD) will report fourth quarter and full-year 2025 financial results after market close on March 9, 2026 and will host a conference call and webcast at 4:30 p.m. Eastern the same day.

Rhea-AI Summary

LifeMD (Nasdaq: LFMD) will report fourth quarter and full-year 2025 financial results after market close on March 9, 2026 and will host a conference call and webcast at 4:30 p.m. Eastern the same day.

Dial-in numbers, conference ID LIFEMD, and a live/archived webcast link will be available for investors.

Argus Feb 23 session

-6.38% close to close Open Argus

Details

News Market Reaction – LFMD

On Feb 23, the day this news came out, LFMD closed 6.38% below the previous close.

Data tracked by StockTitan Argus for the Feb 23 session.

Market Context

On Feb 23, the day this news came out, the stock closed 6.4% below the previous close. A negative re...

Analysis

On Feb 23, the day this news came out, the stock closed 6.4% below the previous close. A negative reaction despite this neutral scheduling announcement would fit a pattern where not all corporate actions support the share price, as seen following the preferred dividend. With the stock trading well below the $7 200-day MA and 82.2% under the 52-week high, sentiment has been weak. Past positive news, including partnerships and credit facilities, often aligned with gains, so a sharp drop here would represent caution ahead of upcoming financial disclosures.

Key Figures

Earnings date: March 9, 2026 Conference call time: 4:30 p.m. Eastern time Toll-free dial-in: 800-343-5172 +1 more

Earnings date

March 9, 2026

Q4 and full-year 2025 financial results release

Conference call time

4:30 p.m. Eastern time

Q4 2025 earnings conference call start time

Toll-free dial-in

800-343-5172

Access number for U.S. participants on earnings call

International dial-in

203-518-9856

Access number for international participants on earnings call

Historical Context

5 past events · Latest: Jan 06

5 events

1. Jan 06

   Credit facility

   24h Move

   +7.9%

   Announced up to $50M senior secured revolving credit facility with Citizens Bank.

2. Jan 05

   Partnership expansion

   24h Move

   +12.0%

   Expanded Novo Nordisk collaboration to offer newly approved Wegovy pill via telehealth.

3. Dec 26

   Preferred dividend

   24h Move

   -12.5%

   Declared cash dividend on 8.875% Series A Cumulative Perpetual Preferred Stock.

4. Nov 24

   Growth recognition

   24h Move

   +3.1%

   Recognized on Deloitte Technology Fast 500 and TIME’s America’s Growth Leaders list.

5. Nov 17

   Q3 2025 earnings

   24h Move

   +2.2%

   Reported Q3 2025 revenue and EBITDA growth with improved balance sheet metrics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date:	Monday, March 9th
Time:	4:30 p.m. Eastern time
Toll-Free Dial-In:	800-343-5172
International Dial-In:	203-518-9856
Conference ID:	LIFEMD
Live & Archived Webcast:	Link

About LifeMD, Inc.

LifeMD^® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com

Media Contact
Jessica Friedeman, Chief Marketing and Product Officer
press@lifemd.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will LifeMD (LFMD) release Q4 and full-year 2025 results?

LifeMD will release results after market close on March 9, 2026. According to the company, the report covers the three and 12 months ended December 31, 2025 with a conference call at 4:30 p.m. ET.

How can investors join the LifeMD (LFMD) earnings call on March 9, 2026?

Investors can join via toll-free dial-in 800-343-5172 or international 203-518-9856. According to the company, use conference ID LIFEMD and the live webcast link for online access.

What time is the LifeMD (LFMD) conference call for Q4 2025 results?

The conference call begins at 4:30 p.m. Eastern time on March 9, 2026. According to the company, a live and archived webcast will also be available for listeners who cannot join by phone.

Will LifeMD (LFMD) provide a webcast of the March 9, 2026 earnings call?

Yes, LifeMD will offer a live and archived webcast of the call. According to the company, the webcast link will be available for real-time listening and subsequent on-demand access.

What information will LifeMD (LFMD) report for the period ending December 31, 2025?

LifeMD will report financial results for the three and 12 months ended December 31, 2025. According to the company, the release will include the complete financial results followed by the conference call discussion.